Vivanza Biosciences informs about board meeting
In continuation of its letter Dated August 08, 2025, Vivanza Biosciences has informed that the Board of Directors of the Company at its meeting held today Wednesday, August 13, 2025 at Registered Office of the Company has considered and approved the Un-audited Standalone and Consolidated Financial Results along with Limited Review Report of the Company for the Quarter ended on 30th June, 2025. (Enclosed). The meeting of Board of Directors of the Company commenced at 3:30 pm and concluded at 4:00 pm.
The above information is a part of company’s filings submitted to BSE.
